BMS-354825
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BMS-354825, covering 2011-04-14 to 2011-04-14. Get the full timeline:
Most recent: Clinical Trial Update: Study of BMS-354825 in Subjects With CML Who Are Resistant to or Intolerant of Imatinib or Ph+All in Japan [Phase 1, Phase 2]